Skip to main content
Top
Published in: Clinical Rheumatology 10/2008

01-10-2008 | Original Article

Tumor necrosis factor-alpha and Interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients

Authors: Omer Ates, Gulen Hatemi, Vedat Hamuryudan, Aysegul Topal-Sarikaya

Published in: Clinical Rheumatology | Issue 10/2008

Login to get access

Abstract

Tumor necrosis factor and interleukin 10 have been implicated in the pathogenesis of rheumatoid arthritis (RA). Certain single-nucleotide polymorphisms (SNPs) within the promoter region of the IL-10 and TNF genes have been associated with altered levels of circulating IL10 and TNF. We aimed to explore the association of IL-10 and TNF-α polymorphisms in Turkish RA patients. We analyzed the association of TNF-α (−308G/A, −238G/A, −376G/A) and IL10 (−1082G/A, −819C/T, −592C/A) polymorphisms in 98 Turkish patients with rheumatoid arthritis and 122 healthy subjects using ARMS-PCR. The correlation of these findings with RF positivity and erosive disease in RA patients was also sought. A significant association was found between having RA and −1082 G allele (p = 0.008; OR = 1.44, 95% CI 1.11–1.86). There was no association between RA and −819C/T polymorphism. Significant differences were observed in IL10 GCC and ACC haplotypes distribution between RA and control subjects (p = 0.006; OR = 1.46, 95% CI 1.13–1.89 and p = 0.011; OR = 1.43, 95% CI 1.09–1.88, respectively). No statistically significant association was found between TNF-α 308G/A, −238G/A, −376G/A polymorphisms and RA. No significant association was found between RF positivity and erosive disease and TNF-α, IL10 gene polymorphisms. In addition, when combined genotypes were analyzed, no significant difference was found between RA patients and healthy controls. Our findings suggest that IL-10 1082 G/A polymorphism or GCC, ACC haplotypes may be associated with RA in Turkish patients.
Literature
1.
go back to reference Albani S, Carson DA, Roudier J (1992) Genetic and environmental factors in the immune pathogenesis of rheumatoid arthritis. Rheum Dis Clin North Am 18:729–740PubMed Albani S, Carson DA, Roudier J (1992) Genetic and environmental factors in the immune pathogenesis of rheumatoid arthritis. Rheum Dis Clin North Am 18:729–740PubMed
2.
go back to reference Kishimoto T, Akira S, Narazaki M, Taga T (1995) Interleukin-6 family of cytokines and gp130. Blood 86:1243–1254PubMed Kishimoto T, Akira S, Narazaki M, Taga T (1995) Interleukin-6 family of cytokines and gp130. Blood 86:1243–1254PubMed
3.
go back to reference De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209–1220PubMedCrossRef De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209–1220PubMedCrossRef
4.
go back to reference Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O’Garra A (1991) IL–10 inhibits cytokine production by activated macrophages. J Immunol 146:3445–3451 Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O’Garra A (1991) IL–10 inhibits cytokine production by activated macrophages. J Immunol 146:3445–3451
5.
go back to reference Takeshita S, Gage JR, Kishimoto T, Vredevoe DL, Martinez-Maza O (1996) Differential regulation of IL-6 gene transcription and expression by IL-4 and IL-10 in human monocytic cell lines. J Immunol 156:2591–2598PubMed Takeshita S, Gage JR, Kishimoto T, Vredevoe DL, Martinez-Maza O (1996) Differential regulation of IL-6 gene transcription and expression by IL-4 and IL-10 in human monocytic cell lines. J Immunol 156:2591–2598PubMed
6.
go back to reference Elbim C, Reglier H, Fay M, Delarche C, Andrieu V, Benna JE et al (2001) Intracellular pool of IL-10 receptors in specific granules of human neutrophils: differential mobilization by proinflammatory mediators. J Immunol 166:5201–5207PubMed Elbim C, Reglier H, Fay M, Delarche C, Andrieu V, Benna JE et al (2001) Intracellular pool of IL-10 receptors in specific granules of human neutrophils: differential mobilization by proinflammatory mediators. J Immunol 166:5201–5207PubMed
7.
go back to reference Donnelly RP, Freeman SL, Hayes MP (1995) Inhibition of IL-10 expression by INF-gamma up-regulates transcription of TNFalpha in human monocytes. J Immunol 155:1420–1427PubMed Donnelly RP, Freeman SL, Hayes MP (1995) Inhibition of IL-10 expression by INF-gamma up-regulates transcription of TNFalpha in human monocytes. J Immunol 155:1420–1427PubMed
8.
go back to reference Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, McDermott MF et al (1999) Cytokine gene polymorphism in human disease: on-line databases. Genes Immunity 1:3–19PubMedCrossRef Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, McDermott MF et al (1999) Cytokine gene polymorphism in human disease: on-line databases. Genes Immunity 1:3–19PubMedCrossRef
9.
go back to reference Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683–765PubMedCrossRef Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683–765PubMedCrossRef
10.
go back to reference Makhatadze NJ (1998) Tumor necrosis factor locus: genetic organisation and biological implications. Hum Immunol 59:571–579PubMedCrossRef Makhatadze NJ (1998) Tumor necrosis factor locus: genetic organisation and biological implications. Hum Immunol 59:571–579PubMedCrossRef
11.
go back to reference Candore G, Lio D, Colonna Romano G, Caruso C (2002) Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions. Autoimmunity Rev 1:29–35CrossRef Candore G, Lio D, Colonna Romano G, Caruso C (2002) Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions. Autoimmunity Rev 1:29–35CrossRef
12.
go back to reference Lio D, Candore G, Colombo A, Colonna Romano G, Gervasi F, Marino V et al (2001) A genetically determined high setting of TNF alpha influences immunological parameters of HLA-B8, DR3 positive subjects: implications for autoimmunity. Hum Immunol 62:705–713PubMedCrossRef Lio D, Candore G, Colombo A, Colonna Romano G, Gervasi F, Marino V et al (2001) A genetically determined high setting of TNF alpha influences immunological parameters of HLA-B8, DR3 positive subjects: implications for autoimmunity. Hum Immunol 62:705–713PubMedCrossRef
13.
go back to reference Hutchinson IV, Pravica V, Hajeer A, Sinnott PJ (1999) Identification of high and low responders to allografts. Rev Immunogenet 1:323–333PubMed Hutchinson IV, Pravica V, Hajeer A, Sinnott PJ (1999) Identification of high and low responders to allografts. Rev Immunogenet 1:323–333PubMed
14.
go back to reference Westendorp RG, Langermans JA, Huizinga TW, Elouali AH, Verveij CL, Boomsma DI et al (1997) Genetic influence on cytokine production and fatal meningococcal disease. Lancet 349:170–173PubMedCrossRef Westendorp RG, Langermans JA, Huizinga TW, Elouali AH, Verveij CL, Boomsma DI et al (1997) Genetic influence on cytokine production and fatal meningococcal disease. Lancet 349:170–173PubMedCrossRef
15.
go back to reference Padyukov L, Hytonen AM, Smolnikova M, Hahn-Zoric M, Nilsson N, Hanson LA et al (2004) Polymorphism in promoter region of IL10 gene is associated with rheumatoid arthritis in women. J Rheumatol 31:422–425PubMed Padyukov L, Hytonen AM, Smolnikova M, Hahn-Zoric M, Nilsson N, Hanson LA et al (2004) Polymorphism in promoter region of IL10 gene is associated with rheumatoid arthritis in women. J Rheumatol 31:422–425PubMed
16.
go back to reference Pawlik A, Kurzawski M, Szklarz BG, Herczynska M, Drozdzik M (2005) Interleukin-10 promoter polymorphism in patients with rheumatoid arthritis. Clin Rheumatol 24:480–484PubMedCrossRef Pawlik A, Kurzawski M, Szklarz BG, Herczynska M, Drozdzik M (2005) Interleukin-10 promoter polymorphism in patients with rheumatoid arthritis. Clin Rheumatol 24:480–484PubMedCrossRef
17.
go back to reference Hajeer AH, Lazarus M, Turner D, Mageed RA, Vencovsky J, Sinnott P et al (1998) IL-10 gene promoter polymorphisms in rheumatoid arthritis. Scand J Rheumatol 27:142–145PubMedCrossRef Hajeer AH, Lazarus M, Turner D, Mageed RA, Vencovsky J, Sinnott P et al (1998) IL-10 gene promoter polymorphisms in rheumatoid arthritis. Scand J Rheumatol 27:142–145PubMedCrossRef
18.
go back to reference Coakley G, Mok CC, Hajeer AH, Ollier WE, Turner D, Sinnott PJ et al (1998) Interleukin-10 promoter polymorphisms in rheumatoid arthritis and Felty’s syndrome. Br J Rheumatol 37:988–991PubMedCrossRef Coakley G, Mok CC, Hajeer AH, Ollier WE, Turner D, Sinnott PJ et al (1998) Interleukin-10 promoter polymorphisms in rheumatoid arthritis and Felty’s syndrome. Br J Rheumatol 37:988–991PubMedCrossRef
19.
go back to reference Cantagrel A, Navaux F, Loubet-Lescoulie P, Nourhashemi F, Enault G, Abbal M et al (1999) Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum 42:1093–1100PubMedCrossRef Cantagrel A, Navaux F, Loubet-Lescoulie P, Nourhashemi F, Enault G, Abbal M et al (1999) Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum 42:1093–1100PubMedCrossRef
20.
go back to reference Martinez A, Pascual M, Pascual-Salcedo D, Balsa A, Martin J, de la Concha EG (2003) Genetic polymorphisms in Spanish rheumatoid arthritis patients: an association and linkage study. Genes Immunity 4:117–121PubMedCrossRef Martinez A, Pascual M, Pascual-Salcedo D, Balsa A, Martin J, de la Concha EG (2003) Genetic polymorphisms in Spanish rheumatoid arthritis patients: an association and linkage study. Genes Immunity 4:117–121PubMedCrossRef
21.
go back to reference Lee YH, Ji JD, Song GG (2007) Tumor necrosis factor-alpha promoter −308 A/G polymorphism and rheumatoid arthritis susceptibility: a metaanalysis. J Rheumatol 34:43–49PubMed Lee YH, Ji JD, Song GG (2007) Tumor necrosis factor-alpha promoter −308 A/G polymorphism and rheumatoid arthritis susceptibility: a metaanalysis. J Rheumatol 34:43–49PubMed
22.
go back to reference Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef
23.
go back to reference Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215PubMedCrossRef Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215PubMedCrossRef
24.
go back to reference Perrey C, Turner SJ, Pravica V, Howell WM, Hutchinson IV (1999) ARMS-PCR methodologies to determine IL-10, TNF-α, TNF-β and TGF- β1 gene polymorphisms. Trans Immunol 7:127–128CrossRef Perrey C, Turner SJ, Pravica V, Howell WM, Hutchinson IV (1999) ARMS-PCR methodologies to determine IL-10, TNF-α, TNF-β and TGF- β1 gene polymorphisms. Trans Immunol 7:127–128CrossRef
25.
go back to reference Richardson A, Sisay-Joof F, Ackerman H, Usen S, Katundu P, Taylor T et al (2001) Nucleotide diversity of the TNF gene region in an African village. Genes Immun 2:343–348PubMedCrossRef Richardson A, Sisay-Joof F, Ackerman H, Usen S, Katundu P, Taylor T et al (2001) Nucleotide diversity of the TNF gene region in an African village. Genes Immun 2:343–348PubMedCrossRef
26.
go back to reference Koss K, Fanning GC, Welsh KI, Jewell DP (2000) Interleukin-10 gene promoter polymorphism in English and Polish healthy controls. Polymerase chain reaction haplotyping using 3¢ mismatches in forward and reverse primers. Genes Immun 1:321–324PubMedCrossRef Koss K, Fanning GC, Welsh KI, Jewell DP (2000) Interleukin-10 gene promoter polymorphism in English and Polish healthy controls. Polymerase chain reaction haplotyping using 3¢ mismatches in forward and reverse primers. Genes Immun 1:321–324PubMedCrossRef
27.
go back to reference Reynard MP, Turner D, Navarrete CV (2000) Allele frequencies of polymorphisms of the tumor necrosis-alpha, interleukin-10, interferon-gamma and interleukin-2 genes in a North European Caucasoid group from the UK. Eur J Immunogenet 27:241–249PubMedCrossRef Reynard MP, Turner D, Navarrete CV (2000) Allele frequencies of polymorphisms of the tumor necrosis-alpha, interleukin-10, interferon-gamma and interleukin-2 genes in a North European Caucasoid group from the UK. Eur J Immunogenet 27:241–249PubMedCrossRef
28.
go back to reference Hoffmann SC, Stanley EM, Cox ED, DiMercurio BS, Koziol DE, Harlan DM et al (2002) Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2:560–567PubMedCrossRef Hoffmann SC, Stanley EM, Cox ED, DiMercurio BS, Koziol DE, Harlan DM et al (2002) Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2:560–567PubMedCrossRef
29.
go back to reference Mok CC, Lanchbury JS, Chan DW, Lau SC (1998) Interleukin 10 promoter polymorphisms in southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 41:1090–1095PubMedCrossRef Mok CC, Lanchbury JS, Chan DW, Lau SC (1998) Interleukin 10 promoter polymorphisms in southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 41:1090–1095PubMedCrossRef
30.
go back to reference Pyo CW, Hur SS, Kim YK, Choi HB, Hong YS, Kim DW et al (2003) Polymorphisms of IL-1B,IL-1RN,IL-2,IL-4,IL-6,IL-10,and IFN-γ genes in the Korean population. Hum Immunol 64:979–989PubMedCrossRef Pyo CW, Hur SS, Kim YK, Choi HB, Hong YS, Kim DW et al (2003) Polymorphisms of IL-1B,IL-1RN,IL-2,IL-4,IL-6,IL-10,and IFN-γ genes in the Korean population. Hum Immunol 64:979–989PubMedCrossRef
31.
go back to reference Ide A, Kawasaki E, Abiru N, Sun F, Takahashi R, Kuwahara H et al (2002) Genetic association between interleukin-10 gene promoter region polymorphisms and type I diabetes age-at-onset. Hum Immunol 63:690–695PubMedCrossRef Ide A, Kawasaki E, Abiru N, Sun F, Takahashi R, Kuwahara H et al (2002) Genetic association between interleukin-10 gene promoter region polymorphisms and type I diabetes age-at-onset. Hum Immunol 63:690–695PubMedCrossRef
32.
go back to reference Waldron-Lynch F, Adams C, Amos C, Zhu DK, McDermott MF, Shanahan F et al (2001) Tumour necrosis factor 5¢ promoter single nucleotide polymorphisms influence susceptibility to rheumatoid arthritis (RA) in immunogenetically defined multiplex RA families. Genes Immun 2:82–87PubMedCrossRef Waldron-Lynch F, Adams C, Amos C, Zhu DK, McDermott MF, Shanahan F et al (2001) Tumour necrosis factor 5¢ promoter single nucleotide polymorphisms influence susceptibility to rheumatoid arthritis (RA) in immunogenetically defined multiplex RA families. Genes Immun 2:82–87PubMedCrossRef
33.
go back to reference Seki N, Kamizono S, Yamada A, Higuchi T, Matsumoto H, Niiya F et al (1999) Polymorphisms in the 59-flanking region of tumor necrosis factor-alpha gene in patients with rheumatoid arthritis. Tissue Antigens 54:194–197PubMedCrossRef Seki N, Kamizono S, Yamada A, Higuchi T, Matsumoto H, Niiya F et al (1999) Polymorphisms in the 59-flanking region of tumor necrosis factor-alpha gene in patients with rheumatoid arthritis. Tissue Antigens 54:194–197PubMedCrossRef
34.
go back to reference Vinasco J, Beraun Y, Nieto A, Fraile A, Mataran L, Pareja E et al (1997) Polymorphism at the TNF loci in rheumatoid arthritis. Tissue Antigens 49:74–78PubMedCrossRef Vinasco J, Beraun Y, Nieto A, Fraile A, Mataran L, Pareja E et al (1997) Polymorphism at the TNF loci in rheumatoid arthritis. Tissue Antigens 49:74–78PubMedCrossRef
35.
go back to reference Yen JH, Chen CJ, Tsai WC, Lin CH, Ou TT, Wu CC et al (2001) Tumor necrosis factor promoter polymorphisms in patients with rheumatoid arthritis in Taiwan. J Rheumatol 28:1788–1792PubMed Yen JH, Chen CJ, Tsai WC, Lin CH, Ou TT, Wu CC et al (2001) Tumor necrosis factor promoter polymorphisms in patients with rheumatoid arthritis in Taiwan. J Rheumatol 28:1788–1792PubMed
36.
go back to reference Barton A, Platt H, Salway F, Symmons D, Barrett E, Bukhari M et al (2004) Polymorphisms in the tumour necrosis factor gene are not associated with severity of inflammatory polyarthritis. Ann Rheum Dis 63:280–284PubMedCrossRef Barton A, Platt H, Salway F, Symmons D, Barrett E, Bukhari M et al (2004) Polymorphisms in the tumour necrosis factor gene are not associated with severity of inflammatory polyarthritis. Ann Rheum Dis 63:280–284PubMedCrossRef
37.
go back to reference Ozen S, Alikasifoglu M, Bakkaloglu A, Duzova A, Jarosova K, Demcova D et al (2002) Tumour necrosis factor-α G-A −238 and G-A −308 polymorphisms in juvenile idiopathic arthritis. Rheumatology 41:223–227PubMedCrossRef Ozen S, Alikasifoglu M, Bakkaloglu A, Duzova A, Jarosova K, Demcova D et al (2002) Tumour necrosis factor-α G-A −238 and G-A −308 polymorphisms in juvenile idiopathic arthritis. Rheumatology 41:223–227PubMedCrossRef
Metadata
Title
Tumor necrosis factor-alpha and Interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients
Authors
Omer Ates
Gulen Hatemi
Vedat Hamuryudan
Aysegul Topal-Sarikaya
Publication date
01-10-2008
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 10/2008
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-008-0893-1

Other articles of this Issue 10/2008

Clinical Rheumatology 10/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.